In this study, the concentration of the biomarkers TPA and CA-125 were measured in serum samples of women with malignant ovarian and uterine tumors, a variety of benign diseases including ovarian cysts and of women without known severe diseases. This evidence concerns the gene MUC16 and tumor of uterus.